Interpreting serum procalcitonin in COVID-19 patients undergoing renal replacement therapy

por Adams, Briony, Beaney, Alec
Publicado 2021

In vitro evaluation of the virucidal activity of disodium citrate perhydrate (2SCP) disinfectant against SARS-CoV-2

por Dessilly, Géraldine, Pâques, Anne-Thérèse, Vandenbroucke, Anne-Thérèse, Hazée, Pierre, Gaume, Alain, Gindro, Katia, Schnée, Sylvain, Lakaye, Frédéric, Kabamba-Mukadi, Benoît
Publicado 2022

Back to the future (of common respiratory viruses)

por Mattana, Giordana, Albitar-Nehme, Sami, Cento, Valeria, Colagrossi, Luna, Piccioni, Livia, Raponi, Massimiliano, Raucci, Umberto, Vittucci, Anna Chiara, Reale, Antonino, Villani, Alberto, Bernaschi, Paola, Perno, Carlo Federico
Publicado 2022

Preexisting conditions among the SARS-CoV2 deaths during the SARS-CoV2 B.1.617.2 (Delta variant) outbreak in the United Kingdom

por Emani, Venkata R., Reddy, Raghunath, Goswami, Kartik K., Nakka, Abirath S., Emani, Shaila R., Reddy, Nikhila K., Maddula, Kailash R., Nandanoor, Dheeraj, Goswami, Sanjeev
Publicado 2022

Overuse of empirical antibiotics in a COVID-19 intensive care unit led to the spread of carbapenem-resistant Gram-negative bacteria in a teaching hospital

por Dambroso-Altafini, Daniela, dos Santos Saalfeld, Silvia Maria, de Souza Ferreira de Mattos, Monica, Martinez, Hilton Vizzi, Shinohara, Danielle Rosani, Zarpellon, Mirian Nicéa, Costa, Bruno Buranello, Bronharo Tognim, Maria Cristina
Publicado 2022

What and where should the next antimicrobial resistance policies focus on?

por Chan, Olivia SK, Tun, Hein Min, Uchea, Chibuzor, Wu, Peng, Fukuda, Keiji
Publicado 2022

In vitro activity of ceftazidime/avibactam against carbapenem-nonsusceptible Klebsiella penumoniae isolates collected during the first wave of the SARS-CoV-2 pandemic: a Southern I...

por La Bella, Gianfranco, Lopizzo, Teresa, Lupo, Laura, Angarano, Rosa, Curci, Anna, Manti, Barbara, La Salandra, Giovanna, Mosca, Adriana, De Nittis, Rosella, Arena, Fabio
Publicado 2022

Effect of farnesyltransferase inhibitors on SARS-CoV-2

por Weber, Lea, Mautner, Lena, Hoyos, Mona, Ehrhardt, Anja, Baiker, Armin, Bachmann, Hagen Sjard
Publicado 2023

Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial

por Kurth, Florian, Helbig, Elisa T., Lippert, Lena J., Thibeault, Charlotte, Barbone, Gianluca, Eckart, Marius A., Kluge, Martin, Puengel, Tobias, Demir, Münevver, Röhle, Robert, Keller, Theresa, Ruwwe-Glösenkamp, Christoph, Witzenrath, Martin, Suttorp, Norbert, von Kalle, Christof, Sander, Leif E., Jochum, Christoph, Tacke, Frank
Publicado 2023

Antibiotic expectation, behaviour, and receipt among patients presenting to emergency departments with uncomplicated upper respiratory tract infection during the COVID-19 pandemic

por Huang, Zhilian, Kuan, Win Sen, Tan, Hann Yee, Seow, Eillyne, Tiah, Ling, Peng, Li Lee, Weng, Yanyi, Chow, Angela
Publicado 2023